Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 4, 2026 · Item 5.07 · Financial statements
Denali Therapeutics Inc.
7
Item 5.07
Jun 4, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Item 5.07 · Financial statements |
| Primary topic | Item 5.07 |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Denali Therapeutics Inc. filed this 8-K to disclose: Employer incorporation) File Number) Identification No. South San Francisco , California 94080 (Address of principal executive offices, including zip code) ( 650 ) 866-8547 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last reports) Check the appropriate box below if the Form 8-K filing i… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 3, 2026 |
| Accession number | 0001714899-26-000074 |
| Reported items | Item 5.07, Financial statements and exhibits See Analysis tab for workforce implications |
